Answers are grounded in this paper and cite their sources.
Background: Measles and rubella (MR) vaccination coverage and MR surveillance were affected by the impact of the COVID-19 pandemic, mainly in the years 2020 and 2021. The strategic plan for measles and rubella elimination and sustenance in the World Health Organization (WHO) Southeast Asia region 2024-2028 aims to achieve and sustain measles and rubella elimination. Objective: To assess vaccination coverage of Measles and Rubella (MR) vaccine, pentavalent vaccine, and fractional IPV among children from 1 to 5 years of age and to assess the critical gaps to achieve measles and rubella elimination in the high-risk areas. Methods: A cross-sectional study was conducted among children aged 1 to 5 years in the selected high-risk areas in Chikkamagaluru district for measles-rubella (MR) elimination gap assessment. The data were collected by house-to-house visits using a pre-tested semi-structured questionnaire. The study was conducted for a period of one month. Cluster sampling technique was used. The sample size was 180 children. Inferential statistics were used for data analysis. Results: Coverage of the 1st dose of the MR vaccine was 98.8%, whereas the coverage of the 2nd dose of the MR vaccine was 94.6 %. Coverage of the 3rd dose of fractional IPV was 47.8%. The main reason for missing the 3rd dose of fractional IPV was unavailability of fIPV (74.5%). Conclusion: The vaccination coverage of the 2nd dose of MR vaccine was 94.6 %. Planning level assessment was found to be satisfactory.
No takes yet. Share an insight, caveat, or question.
Kambale et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: